Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients (Q80633208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

title

Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Etienne-Grimaldi MC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

Cardot JM

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

François E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

Renée N

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

Douillard JY

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

Gamelin E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

Milano G

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

publication date

18 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

413-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronothe

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Quality of Life in Operable Colon Cancer Patients Receiving Oral Compared With Intravenous Chemotherapy: Results From National Surgical Adjuvant Breast and Bowel Project Trial C-06

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100297

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637782 AND SRC:MED&resulttype=core&format=json

2 January 2020

1 reference